{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:48:08Z","timestamp":1792666088866,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T00:00:00Z","timestamp":1357084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-1","type":"journal-article","created":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T11:13:56Z","timestamp":1357125236000},"source":"Crossref","is-referenced-by-count":157,"title":["Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome"],"prefix":"10.1186","volume":"13","author":[{"given":"Emman","family":"Shubbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik\u00f3","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Hajizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshima Z","family":"Parris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szil\u00e1rd","family":"Nemes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Gunnarsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"Einbeigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Helou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,2]]},"reference":[{"issue":"1","key":"3597_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ijc.1571","volume":"97","author":"P Pisani","year":"2002","unstructured":"Pisani P, Bray F, Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002, 97 (1): 72-81. 10.1002\/ijc.1571.","journal-title":"Int J Cancer"},{"issue":"13","key":"3597_CR2","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1158\/1078-0432.CCR-10-0880","volume":"16","author":"SN Khleif","year":"2010","unstructured":"Khleif SN, Doroshow JH, Hait WN: AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development. Clin Cancer Res. 2010, 16 (13): 3299-3318. 10.1158\/1078-0432.CCR-10-0880.","journal-title":"Clin Cancer Res"},{"issue":"6797","key":"3597_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al: Molecular portraits of human breast tumours. Nature. 2000, 406 (6797): 747-752. 10.1038\/35021093.","journal-title":"Nature"},{"issue":"4","key":"3597_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.cll.2005.08.012","volume":"25","author":"S Masood","year":"2005","unstructured":"Masood S: Prognostic\/predictive factors in breast cancer. Clin Lab Med. 2005, 25 (4): 809-825. 10.1016\/j.cll.2005.08.012.","journal-title":"Clin Lab Med"},{"issue":"22","key":"3597_CR5","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.2008.16.1026","volume":"26","author":"E Andreopoulou","year":"2008","unstructured":"Andreopoulou E, Hortobagyi GN: Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy. J Clin Oncol. 2008, 26 (22): 3660-3662. 10.1200\/JCO.2008.16.1026.","journal-title":"J Clin Oncol"},{"key":"3597_CR6","volume-title":"Cancer incidence in Sweden 2010","author":"Socialstyrelsen","year":"2010","unstructured":"Socialstyrelsen: Cancer incidence in Sweden 2010. 2010"},{"issue":"15","key":"3597_CR7","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1158\/1078-0432.CCR-10-0889","volume":"16","author":"TZ Parris","year":"2010","unstructured":"Parris TZ, Danielsson A, Nemes S, Kovacs A, Delle U, Fallenius G, Mollerstrom E, Karlsson P, Helou K: Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma. Clin Cancer Res. 2010, 16 (15): 3860-3874. 10.1158\/1078-0432.CCR-10-0889.","journal-title":"Clin Cancer Res"},{"issue":"3A","key":"3597_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1046\/j.1365-2559.2002.14691.x","volume":"41","author":"CW Elston","year":"2002","unstructured":"Elston CW, Ellis IO: Pathological prognostic factors in breast cancer, I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 2002, 41 (3A): 154-161.","journal-title":"Histopathology"},{"issue":"5","key":"3597_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/0092-8674(89)90687-9","volume":"56","author":"G Draetta","year":"1989","unstructured":"Draetta G, Luca F, Westendorf J, Brizuela L, Ruderman J, Beach D: Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF. Cell. 1989, 56 (5): 829-838.","journal-title":"Cell"},{"issue":"3","key":"3597_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ncb1834","volume":"11","author":"M van der Voet","year":"2009","unstructured":"van der Voet M, Berends CW, Perreault A, Nguyen-Ngoc T, Gonczy P, Vidal M, Boxem M, van den Heuvel S: NuMA-related LIN-5, ASPM-1, calmodulin and dynein promote meiotic spindle rotation independently of cortical LIN-5\/GPR\/Galpha. Nat Cell Biol. 2009, 11 (3): 269-277. 10.1038\/ncb1834.","journal-title":"Nat Cell Biol"},{"key":"3597_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2121-11-85","volume":"11","author":"J Higgins","year":"2010","unstructured":"Higgins J, Midgley C, Bergh AM, Bell SM, Askham JM, Roberts E, Binns RK, Sharif SM, Bennett C, Glover DM, et al: Human ASPM participates in spindle organisation, spindle orientation and cytokinesis. BMC Cell Biol. 2010, 11: 85-10.1186\/1471-2121-11-85.","journal-title":"BMC Cell Biol"},{"issue":"1","key":"3597_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yexcr.2005.09.020","volume":"312","author":"F Simpson","year":"2006","unstructured":"Simpson F, Lammerts Van Bueren K, Butterfield N, Bennetts JS, Bowles J, Adolphe C, Simms LA, Young J, Walsh MD, Leggett B, et al: The PCNA-associated factor KIAA0101\/p15(PAF) binds the potential tumor suppressor product p33ING1b. Exp Cell Res. 2006, 312 (1): 73-85. 10.1016\/j.yexcr.2005.09.020.","journal-title":"Exp Cell Res"},{"issue":"13","key":"3597_CR13","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1158\/0008-5472.CAN-05-0536","volume":"65","author":"RC Osthus","year":"2005","unstructured":"Osthus RC, Karim B, Prescott JE, Smith BD, McDevitt M, Huso DL, Dang CV: The Myc target gene JPO1\/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo. Cancer Res. 2005, 65 (13): 5620-5627. 10.1158\/0008-5472.CAN-05-0536.","journal-title":"Cancer Res"},{"issue":"5","key":"3597_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00424-003-1106-z","volume":"447","author":"A Stahl","year":"2004","unstructured":"Stahl A: A current review of fatty acid transport proteins (SLC27). Pflugers Arch. 2004, 447 (5): 722-727. 10.1007\/s00424-003-1106-z.","journal-title":"Pflugers Arch"},{"issue":"21","key":"3597_CR15","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1038\/sj.onc.1202658","volume":"18","author":"K Helou","year":"1999","unstructured":"Helou K, Wallenius V, Qiu Y, Ohman F, Stahl F, Klinga-Levan K, Kindblom LG, Mandahl N, Jansson JO, Levan G: Amplification and overexpression of the hepatocyte growth factor receptor (HGFR\/MET) in rat DMBA sarcomas. Oncogene. 1999, 18 (21): 3226-3234. 10.1038\/sj.onc.1202658.","journal-title":"Oncogene"},{"issue":"1","key":"3597_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10549-011-1920-5","volume":"134","author":"E Shubbar","year":"2011","unstructured":"Shubbar E, Vegfors J, Carlstrom M, Petersson S, Enerback C: Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Breast Cancer Res Treat. 2011, 134 (1): 71-80.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3597_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y: Survival model predictive accuracy and ROC curves. Biometrics. 2005, 61 (1): 92-105. 10.1111\/j.0006-341X.2005.030814.x.","journal-title":"Biometrics"},{"issue":"1","key":"3597_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1023\/B:JOMG.0000023591.45568.77","volume":"9","author":"RL Sutherland","year":"2004","unstructured":"Sutherland RL, Musgrove EA: Cyclins and breast cancer. J Mammary Gland Biol Neoplasia. 2004, 9 (1): 95-104.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"20","key":"3597_CR19","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1056\/NEJMoa021153","volume":"347","author":"K Keyomarsi","year":"2002","unstructured":"Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, et al: Cyclin E and survival in patients with breast cancer. N Engl J Med. 2002, 347 (20): 1566-1575. 10.1056\/NEJMoa021153.","journal-title":"N Engl J Med"},{"issue":"1","key":"3597_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/bcr411","volume":"4","author":"RL Sutherland","year":"2002","unstructured":"Sutherland RL, Musgrove EA: Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models. Breast cancer research: BCR. 2002, 4 (1): 14-17. 10.1186\/bcr411.","journal-title":"Breast cancer research: BCR"},{"issue":"6B","key":"3597_CR21","first-page":"4415","volume":"26","author":"E Baldini","year":"2006","unstructured":"Baldini E, Camerini A, Sgambato A, Prochilo T, Capodanno A, Pasqualetti F, Orlandini C, Resta L, Bevilacqua G, Collecchi P: Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients. Anticancer Res. 2006, 26 (6B): 4415-4421.","journal-title":"Anticancer Res"},{"issue":"11","key":"3597_CR22","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.4161\/cc.6.11.4297","volume":"6","author":"ET Petri","year":"2007","unstructured":"Petri ET, Errico A, Escobedo L, Hunt T, Basavappa R: The crystal structure of human cyclin B. Cell Cycle. 2007, 6 (11): 1342-1349. 10.4161\/cc.6.11.4297.","journal-title":"Cell Cycle"},{"issue":"24","key":"3597_CR23","doi-asserted-by":"publisher","first-page":"18291","DOI":"10.1074\/jbc.M110.106575","volume":"285","author":"T Wu","year":"2010","unstructured":"Wu T, Zhang X, Huang X, Yang Y, Hua X: Regulation of cyclin B2 expression and cell cycle G2\/m transition by menin. J Biol Chem. 2010, 285 (24): 18291-18300. 10.1074\/jbc.M110.106575.","journal-title":"J Biol Chem"},{"issue":"5","key":"3597_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1164\/rccm.200401-127OC","volume":"170","author":"HS Hofmann","year":"2004","unstructured":"Hofmann HS, Hansen G, Burdach S, Bartling B, Silber RE, Simm A: Discrimination of human lung neoplasm from normal lung by two target genes. Am J Respir Crit Care Med. 2004, 170 (5): 516-519. 10.1164\/rccm.200407-127OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3597_CR25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5301\/JBM.2008.3142","volume":"22","author":"D Stav","year":"2007","unstructured":"Stav D, Bar I, Sandbank J: Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma. Int J Biol Markers. 2007, 22 (2): 108-113.","journal-title":"Int J Biol Markers"},{"issue":"3","key":"3597_CR26","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1158\/1078-0432.CCR-06-1461","volume":"13","author":"SH Park","year":"2007","unstructured":"Park SH, Yu GR, Kim WH, Moon WS, Kim JH, Kim DG: NF-Y-dependent cyclin B2 expression in colorectal adenocarcinoma. Clin Cancer Res. 2007, 13 (3): 858-867. 10.1158\/1078-0432.CCR-06-1461.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3597_CR27","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1158\/0008-5472.CAN-08-4133","volume":"69","author":"I De Martino","year":"2009","unstructured":"De Martino I, Visone R, Wierinckx A, Palmieri D, Ferraro A, Cappabianca P, Chiappetta G, Forzati F, Lombardi G, Colao A, et al: HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res. 2009, 69 (5): 1844-1850. 10.1158\/0008-5472.CAN-08-4133.","journal-title":"Cancer Res"},{"issue":"4","key":"3597_CR28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5301\/JBM.2010.6088","volume":"25","author":"ML Mo","year":"2010","unstructured":"Mo ML, Chen Z, Li J, Li HL, Sheng Q, Ma HY, Zhang FX, Hua YW, Zhang X, Sun DQ, et al: Use of serum circulating CCNB2 in cancer surveillance. Int J Biol Markers. 2010, 25 (4): 236-242.","journal-title":"Int J Biol Markers"},{"issue":"6871","key":"3597_CR29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"V't Veer LJ","year":"2002","unstructured":"Veer LJ V't, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002, 415 (6871): 530-536. 10.1038\/415530a.","journal-title":"Nature"},{"issue":"27","key":"3597_CR30","doi-asserted-by":"publisher","first-page":"10438","DOI":"10.1073\/pnas.0604066103","volume":"103","author":"JL Fish","year":"2006","unstructured":"Fish JL, Kosodo Y, Enard W, Paabo S, Huttner WB: Aspm specifically maintains symmetric proliferative divisions of neuroepithelial cells. Proc Natl Acad Sci U S A. 2006, 103 (27): 10438-10443. 10.1073\/pnas.0604066103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"3597_CR31","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4161\/cc.6.13.4356","volume":"6","author":"M Paramasivam","year":"2007","unstructured":"Paramasivam M, Chang YJ, LoTurco JJ: ASPM and citron kinase co-localize to the midbody ring during cytokinesis. Cell Cycle. 2007, 6 (13): 1605-1612. 10.4161\/cc.6.13.4356.","journal-title":"Cell Cycle"},{"issue":"46","key":"3597_CR32","doi-asserted-by":"publisher","first-page":"17402","DOI":"10.1073\/pnas.0608396103","volume":"103","author":"S Horvath","year":"2006","unstructured":"Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, et al: Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A. 2006, 103 (46): 17402-17407. 10.1073\/pnas.0608396103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"3597_CR33","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1158\/1078-0432.CCR-07-5262","volume":"14","author":"SY Lin","year":"2008","unstructured":"Lin SY, Pan HW, Liu SH, Jeng YM, Hu FC, Peng SY, Lai PL, Hsu HC: ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res. 2008, 14 (15): 4814-4820. 10.1158\/1078-0432.CCR-07-5262.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3597_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00381-010-1252-5","volume":"27","author":"TM Vulcani-Freitas","year":"2011","unstructured":"Vulcani-Freitas TM, Saba-Silva N, Cappellano A, Cavalheiro S, Marie SK, Oba-Shinjo SM, Malheiros SM, de Toledo SR: ASPM gene expression in medulloblastoma. Childs Nerv Syst. 2011, 27 (1): 71-74. 10.1007\/s00381-010-1252-5.","journal-title":"Childs Nerv Syst"},{"issue":"10","key":"3597_CR35","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/bjc.2011.117","volume":"104","author":"A Bruning-Richardson","year":"2011","unstructured":"Bruning-Richardson A, Bond J, Alsiary R, Richardson J, Cairns DA, McCormack L, Hutson R, Burns P, Wilkinson N, Hall GD, et al: ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival. Br J Cancer. 2011, 104 (10): 1602-1610. 10.1038\/bjc.2011.117.","journal-title":"Br J Cancer"},{"issue":"43","key":"3597_CR36","doi-asserted-by":"publisher","first-page":"29396","DOI":"10.1074\/jbc.M802821200","volume":"283","author":"SC Wu","year":"2008","unstructured":"Wu SC, Chang SC, Wu HY, Liao PJ, Chang MF: Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway. J Biol Chem. 2008, 283 (43): 29396-29404. 10.1074\/jbc.M802821200.","journal-title":"J Biol Chem"},{"issue":"5","key":"3597_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1215\/15228517-2008-113","volume":"11","author":"JG Hodgson","year":"2009","unstructured":"Hodgson JG, Yeh RF, Ray A, Wang NJ, Smirnov I, Yu M, Hariono S, Silber J, Feiler HS, Gray JW, et al: Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neuro Oncol. 2009, 11 (5): 477-487. 10.1215\/15228517-2008-113.","journal-title":"Neuro Oncol"},{"key":"3597_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-10-1","volume":"10","author":"SN Bikeye","year":"2010","unstructured":"Bikeye SN, Colin C, Marie Y, Vampouille R, Ravassard P, Rousseau A, Boisselier B, Idbaih A, Calvo CF, Leuraud P, et al: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target. Cancer Cell Int. 2010, 10: 1-10.1186\/1475-2867-10-1.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"3597_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/sj.onc.1204113","volume":"20","author":"P Yu","year":"2001","unstructured":"Yu P, Huang B, Shen M, Lau C, Chan E, Michel J, Xiong Y, Payan DG, Luo Y: p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene. 2001, 20 (4): 484-489. 10.1038\/sj.onc.1204113.","journal-title":"Oncogene"},{"issue":"7","key":"3597_CR40","first-page":"3124","volume":"61","author":"DA Notterman","year":"2001","unstructured":"Notterman DA, Alon U, Sierk AJ, Levine AJ: Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 2001, 61 (7): 3124-3130.","journal-title":"Cancer Res"},{"issue":"46","key":"3597_CR41","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1038\/sj.onc.1207921","volume":"23","author":"J Petroziello","year":"2004","unstructured":"Petroziello J, Yamane A, Westendorf L, Thompson M, McDonagh C, Cerveny C, Law CL, Wahl A, Carter P: Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer. Oncogene. 2004, 23 (46): 7734-7745. 10.1038\/sj.onc.1207921.","journal-title":"Oncogene"},{"issue":"1","key":"3597_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.lungcan.2011.05.024","volume":"75","author":"T Kato","year":"2012","unstructured":"Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kaji M: Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients. Lung Cancer. 2012, 75 (1): 110-118. 10.1016\/j.lungcan.2011.05.024.","journal-title":"Lung Cancer"},{"issue":"8","key":"3597_CR43","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1158\/1541-7786.MCR-10-0503","volume":"9","author":"Z Kais","year":"2011","unstructured":"Kais Z, Barsky SH, Mathsyaraja H, Zha A, Ransburgh DJ, He G, Pilarski RT, Shapiro CL, Huang K, Parvin JD: KIAA0101 interacts with BRCA1 and regulates centrosome number. Mol Cancer Res. 2011, 9 (8): 1091-1099. 10.1158\/1541-7786.MCR-10-0503.","journal-title":"Mol Cancer Res"},{"issue":"5518","key":"3597_CR44","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.292.5518.929","volume":"292","author":"T Ideker","year":"2001","unstructured":"Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, Eng JK, Bumgarner R, Goodlett DR, Aebersold R, Hood L: Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science. 2001, 292 (5518): 929-934. 10.1126\/science.292.5518.929.","journal-title":"Science"},{"issue":"3","key":"3597_CR45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ymeth.2004.08.021","volume":"35","author":"B Cox","year":"2005","unstructured":"Cox B, Kislinger T, Emili A: Integrating gene and protein expression data: pattern analysis and profile mining. Methods. 2005, 35 (3): 303-314. 10.1016\/j.ymeth.2004.08.021.","journal-title":"Methods"},{"key":"3597_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8166-2-18","volume":"2","author":"Y Yi","year":"2009","unstructured":"Yi Y, Nandana S, Case T, NElston C, Radmilovic T, Matusik RJ, Tsuchiya KD: Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer. Mol Cytogenet. 2009, 2: 18-10.1186\/1755-8166-2-18.","journal-title":"Mol Cytogenet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T19:37:08Z","timestamp":1562528228000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3597"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,2]]},"article-number":"1"}}